Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapitinib + FOLFIRI in Metastatic Colorectal Cancer (PANTHER)
NCT01862003Phase 2Completed
- Sponsor
- University College London
- Start
- May 2014
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sapitinib in colorectal cancer (CRC), sponsored by University College London. Started May 2014; status: completed.
02
Drugs
sapitinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01862003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01862003.